Symphony Pharma Lifesciences Private Limited - Company Profile

It is a pharma private limited company based in Kolthur Village, Telangana, India, established in 2007.
2007 Kolthur Village, Telangana, India Active
Last Updated:
Access Report
About Symphony Pharma Lifesciences Private Limited

Symphony Pharma Lifesciences Private Limited, a active private limited company, was established on 05 December 2007 in Kolthur Village, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U73100TG2007PTC056533. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹25.00 Cr and a paid-up capital of ₹23.99 Cr.

It upholds a compliant status. Employing 49 professional, Its leadership includes Amar Paduru Reddy (Director), Raju Sirisilla (Director), Gouravaram Nageshwar Reddy (Director). Past directors included Buchireddy Gauravaram, Amar Paduru Reddy, Mohan Reddy Paduru. It holds ₹1.90 Cr open charges and ₹5.32 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.: 7/A, Biotech Park, Phase - Ii Genome Vally, Shamirpet(Mandal), Kolthur Village, Telangana, 500078.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U73100TG2007PTC056533

  • Registration Number

    056533

  • Incorporation Date

    05 December 2007

  • Authorized Capital

    ₹25.00 Cr

  • Paid-Up Capital

    ₹23.99 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 25.00 Cr
  • Paid Up Capital ₹ 23.99 Cr
  • Company Age 18 Year, 2 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 1.90 Cr
  • Satisfied Charges ₹ 5.32 M
  • Revenue Growth **** 1.64%
  • Profit Growth **** 33.32%
  • Ebitda **** -42.15%
  • Net Worth 16.33%
  • Total Assets **** 17.55%
Company report

Symphony Pharma Lifesciences Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Symphony Pharma Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Symphony Pharma Lifesciences Private Limited?
Current Directors
Name Designation Appointment Date Status
Amar Paduru Reddy Director 06 Oct 2023 Current
Raju Sirisilla Director 01 Apr 2024 Current
Gouravaram Nageshwar Reddy Director 19 Jul 2023 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2011 Past
Pramod Abcsdd Additional Director 27 Sep 2024 Past
Pramod Abcsdd Director 04 Nov 2024 Past
Pramod Abcsdd Director 01 Sep 2010 Past
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Company Secretary - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Symphony Pharma Lifesciences.

Symphony Pharma Lifesciences Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.64% increase. The company also saw a substantial improvement in profitability, with a 33.32% increase in profit. The company's net worth Soared by an impressive increase of 16.33%.

Symphony Pharma Lifesciences revenue growth over time
Symphony Pharma Lifesciences profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 1.64%
*******
*******
*******
*******
Revenue from Operations
*******
 -1.16%
*******
*******
*******
*******
Total Assets
*******
 17.55%
*******
*******
*******
*******
Profit or Loss
*******
 33.32%
*******
*******
*******
*******
Net Worth
*******
 16.33%
*******
*******
*******
*******
EBITDA
*******
 -42.15%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Symphony Pharma Lifesciences?

In 2022, Symphony Pharma Lifesciences had a promoter holding of 96.41% and a public holding of 3.59%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹19,000,000.00

Satisfied Charges

₹5,318,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 1.90 Cr
Latest Charge Details
Date Lender Amount Status
05 May 2022 Hdfc Bank Limited ₹1.90 Cr Open
11 May 2021 Hdfc Bank Limited ₹1.32 M Satisfied
27 Sep 2010 Andhra Bank ₹4.00 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Symphony Pharma Lifesciences?

Symphony Pharma Lifesciences has a workforce of 49 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Symphony Pharma Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Symphony Pharma Lifesciences's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Symphony Pharma Lifesciences
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Symphony Pharma Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Charges

    A charge registered on 11 May 2021 via Charge ID 100452286 with Hdfc Bank Limited was fully satisfied on 08 May 2024. was recorded as a recent event.

  • Director Appointment

    The activity Raju Sirisilla was appointed as a Director was appointed as a Director on 01 Apr 2024 & has been associated with this company since 1 year 10 months . was completed.

  • Balance Sheet

    Symphony Pharma Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.

  • Director Appointment

    The activity Amar Paduru Reddy was appointed as a Director was appointed as a Director on 06 Oct 2023 & has been associated with this company since 2 years 4 months . was completed.

  • Director Appointment

    Progress on Gouravaram Nageshwar Reddy was appointed as a Director was appointed as a Director on 19 Jul 2023 & has been associated with this company since 2 years 7 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Symphony Pharma Lifesciences Private Limited?

The CIN of Symphony Pharma Lifesciences Private Limited is U73100TG2007PTC056533.

Where is Symphony Pharma Lifesciences Private Limited headquartered?

Symphony Pharma Lifesciences Private Limited is headquartered at Plot No.: 7/A, Biotech Park, Phase - Ii Genome Vally, Shamirpet(Mandal), Kolthur Village, Telangana, 500078.

When was Symphony Pharma Lifesciences Private Limited incorporated?

Symphony Pharma Lifesciences Private Limited was incorporated on 05 December 2007.

Who are the current directors of Symphony Pharma Lifesciences Private Limited?

The current directors of Symphony Pharma Lifesciences Private Limited are

What is the primary industry of Symphony Pharma Lifesciences Private Limited?

The primary industry of Symphony Pharma Lifesciences Private Limited is Manufacturing.

Is Symphony Pharma Lifesciences Private Limited a listed company?

Symphony Pharma Lifesciences Private Limited is unlisted.

What is the capital structure of Symphony Pharma Lifesciences Private Limited?

The authorized capital of Symphony Pharma Lifesciences Private Limited is ₹25.00 Cr, and the paid-up capital is ₹23.99 Cr.

What is the compliance status of Symphony Pharma Lifesciences Private Limited?

The compliance status of Symphony Pharma Lifesciences Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available